Holen Sie sich die Stockscreener-App
78.84
0.39%
-0.31
Handel nachbörslich:
78.84
Schlusskurs vom Vortag:
$79.15
Offen:
$79.64
24-Stunden-Volumen:
1.13M
Relative Volume:
0.86
Marktkapitalisierung:
$9.05B
Einnahmen:
$13.18B
Nettoeinkommen (Verlust:
$419.00M
KGV:
24.11
EPS:
3.2704
Netto-Cashflow:
$521.00M
1W Leistung:
+2.12%
1M Leistung:
+9.06%
6M Leistung:
+22.75%
1J Leistung:
+24.98%
1-Tages-Spanne:
$78.56
$81.10
1-Wochen-Bereich:
$76.73
$81.10
52-Wochen-Spanne:
$61.95
$89.29
Henry Schein Inc Stock (HSIC) Company Profile
Firmenname
Henry Schein Inc
Sektor
Branche
Telefon
(631) 843-5500
Adresse
135 DURYEA RD, MELVILLE, NY
Compare HSIC vs MCK, COR, CAH, AHG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
78.84 | 9.08B | 13.18B | 419.00M | 521.00M | 3.2704 |
MCK
Mckesson Corp
|
842.25 | 105.22B | 397.96B | 4.55B | 9.64B | 34.77 |
COR
Cencora Inc
|
312.39 | 62.84B | 325.78B | 1.64B | 3.61B | 8.3139 |
CAH
Cardinal Health Inc
|
204.92 | 49.69B | 244.67B | 1.68B | 5.51B | 6.9487 |
AHG
Akso Health Group Adr
|
1.98 | 1.69B | 14.85M | -136.07M | 7.25M | -0.4726 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-16 | Eingeleitet | BTIG Research | Neutral |
| 2026-04-15 | Eingeleitet | Citigroup | Buy |
| 2026-02-23 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-08-26 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2025-07-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Eingeleitet | Wells Fargo | Equal Weight |
| 2025-01-06 | Hochstufung | BofA Securities | Underperform → Buy |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-07-22 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Hochstufung | Stifel | Hold → Buy |
| 2022-08-08 | Hochstufung | UBS | Sell → Neutral |
| 2022-07-21 | Herabstufung | Goldman | Buy → Neutral |
| 2022-06-14 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-01-31 | Eingeleitet | Morgan Stanley | Underweight |
| 2022-01-07 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Fortgesetzt | Credit Suisse | Neutral |
| 2021-02-08 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-01-04 | Hochstufung | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Hochstufung | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Hochstufung | Goldman | Neutral → Buy |
| 2020-04-02 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Herabstufung | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Eingeleitet | Wolfe Research | Underperform |
| 2019-05-15 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-01-17 | Eingeleitet | UBS | Sell |
| 2019-01-03 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Bestätigt | Barrington Research | Outperform |
| 2018-10-25 | Herabstufung | Edward Jones | Hold → Sell |
| 2018-10-19 | Fortgesetzt | Goldman | Neutral |
| 2018-10-04 | Bestätigt | Robert W. Baird | Outperform |
| 2018-08-07 | Bestätigt | Stifel | Hold |
| 2018-04-24 | Herabstufung | Goldman | Buy → Neutral |
| 2018-04-04 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
Alle ansehen
Henry Schein Inc Aktie (HSIC) Neueste Nachrichten
Henry Schein downgraded at Stifel on market share concerns - MSN
Henry Schein to Release Q1 2026 Results - Dentistry Today
Henry Schein to Webcast First Quarter 2026 Conference Call on Tuesday, May 5, 2026, at 8:00 A.M. ET - Business Wire
How Henry Schein’s Board Overhaul and Bergman’s Exit At Henry Schein (HSIC) Has Changed Its Investment Story - simplywall.st
Henry Schein, Inc. (HSIC) Stock Analysis: Exploring a 14.17% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Henry Schein (NASDAQ:HSIC) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Why Henry Schein (HSIC) is Poised to Beat Earnings Estimates Again - Yahoo Finance
Here's why Henry Schein (HSIC) is a strong value stock - MSN
BTIG initiates coverage of Henry Schein (HSIC) with neutral recommendation - MSN
BTIG initiates Henry Schein stock coverage with Neutral on modest growth - Investing.com
Citigroup initiates coverage of Henry Schein (HSIC) with buy recommendation - MSN
Citigroup Initiates Henry Schein at Buy With $100 Price Target - Moomoo
Henry Schein (HSIC) down 9.4% since last earnings report: Can it rebound? - MSN
Henry Schein (HSIC) Valuation Check As Board Restructuring And Leadership Changes Take Shape - Sahm
Why Henry Schein (HSIC) is a Top Growth Stock for the Long-Term - Yahoo Finance
Henry Schein shrinks board as long-serving chairman retires - MSN
Henry Schein (HSIC) price target increased by 12.37% to 90.80 - MSN
Henry Schein’s Board Overhaul and Bergman Exit Might Change The Case For Investing In HSIC - simplywall.st
What to expect from Henry Schein’s Q1 2026 earnings report - MSN
At US$75.34, Is Henry Schein, Inc. (NASDAQ:HSIC) Worth Looking At Closely? - Moomoo
What to Expect From Henry Schein’s Q1 2026 Earnings Report - Yahoo Finance
How Investors Are Reacting To Henry Schein (HSIC) Board Overhaul After Bergman’s Retirement - Yahoo Finance
Palestra Capital Management LLC's Henry Schein Inc(HSIC) Holding History - GuruFocus
A Look At Henry Schein (HSIC) Valuation As Board Overhaul Reshapes Governance - Yahoo Finance
Henry Schein Inc. stock rises Wednesday, still underperforms market - MarketWatch
HSIC Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Henry Schein board to shrink to 10 members after annual meeting By Investing.com - Investing.com South Africa
Henry Schein Announces Board Reduction Plan - dentistrytoday.com
Henry Schein, Inc. Announces Board Retirements - marketscreener.com
Henry Schein (HSIC) Announces Board of Directors Restructuring - GuruFocus
Henry Schein : 2026 Proxy Statement of 2025 - marketscreener.com
Henry Schein board to shrink to 10 members after annual meeting - Investing.com
Henry Schein (HSIC) 2026 proxy details CEO transition, KKR 16.4% stake and board cuts - Stock Titan
Henry Schein to Reduce Size of the Board of Directors following 2026 Annual Meeting of Stockholders - Business Wire
Williams, Henry Schein, and 3 Other Bargain Stocks From a Veteran Value Fund Manager - Barron's
Henry Schein, Inc. (NASDAQ:HSIC) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
231,651 Shares in Henry Schein, Inc. $HSIC Acquired by Tudor Investment Corp ET AL - MarketBeat
HSIC Technical Analysis & Stock Price Forecast - Intellectia AI
Assessing Henry Schein (HSIC) Valuation As Recent Share Price Moves Draw Fresh Attention - Sahm
Henry Schein, Inc. (HSIC) stock price, news, quote and history - Yahoo Finance UK
Entry Recap: Is Henry Schein Inc still a buy after recent gainsTrade Ideas & Low Risk Entry Point Tips - baoquankhu1.vn
Henry Schein, Inc. (HSIC) Stock Forecasts - Yahoo Finance
Finanzdaten der Henry Schein Inc-Aktie (HSIC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
5.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):